Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px
Document › Details

MeVis Medical Solutions AG. (12/17/14). "Press Release: Executive Board and Supervisory Board welcome public takeover offer of VMS Deutschland Holdings GmbH [Ad hoc announcement]". Bremen.

Organisations Organisation MeVis Medical Solutions AG
  Group Varian Medical Systems (Group)
  Organisation 2 VMS Deutschland Holdings GmbH
  Group Varian Medical Systems (Group)
Products Product MeVisLab™ software platform
  Product 2 medical device
Index term Index term MeVis–Varian Medical Systems: investment, 201412–201504 public cash tender offer €30m with €17.5/share
     


Today, VMS Deutschland Holdings GmbH based in Darmstadt, an affiliate of Varian Medical Systems, Inc., Palo Alto, California, USA, has published pursuant to Section 10 WpÜG its decision to make a voluntary public takeover offer to all shareholders of MeVis Medical Solutions AG to acquire their registered non-par value shares against payment of EUR 17.50 per share. The offer is intended to be subject to the condition of a minimum acceptance rate of 75 % of the shares issued by MeVis Medical Solutions AG (excluding treasury shares).

According to the VMS Deutschland Holdings GmbH a number of major shareholders have irrevocably undertaken to accept the offer of the VMS Deutschland Holdings GmbH; this corresponds to a total of over 70 % of the shares issued by the MeVis Medical Solutions AG (excluding treasury shares).

The Executive Board and Supervisory Board of the MeVis Medical Solutions AG will carefully review the offer and publish a statement pursuant to § 27 WpÜG within two weeks after publication of the offer document. According to their initial assessment the Executive Board and Supervisory Board welcome the offer in principal and consider Varian Medical Systems a reliable partner for the further development of the MeVis Medical Solutions AG.

Varian Medical Systems is the world's leading manufacturer of medical devices and software for treating cancer and other diseases through radiotherapy, proton therapy, and brachytherapy.

   
Record changed: 2017-04-02

Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px

More documents for Varian Medical Systems (Group)


To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BCNP Consultants European Chemistry Partnering 2018 Ffm 120x180px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture BCNP Consultants European Chemistry Partnering 2018 Ffm 120x180px